---

name: gmp-sop language: en description: >- Drafts inspection-ready GMP standard operating procedures for regulated manufacturing. Covers document control, role accountability, process controls, deviation/CAPA handling, and records management aligned to FDA CGMP (21 CFR 210/211), Part 11, ICH Q7/Q9/Q10, WHO GMP, PIC/S, and EU GMP. Use when creating or overhauling a GMP SOP, preparing for audits or inspections, or building compliance-ready procedures. Trigger: GMP, SOP, CGMP, 21 CFR 210, 21 CFR 211, Part 11, ICH Q7, ICH Q9, ICH Q10, WHO GMP, PIC/S, EU GMP.

GMP Standard Operating Procedure

Produces a GMP-compliant SOP that is inspection-ready and operationally executable.

Quick Start

1. Gather inputs: process scope, applicable regulations, QMS context, equipment list, record systems.
2. Walk through each SOP section below, filling tables and templates.
3. Mark any unverified citations with [VERIFY].
4. Route for QA review and approval before release.

Prerequisites

Collect before drafting:

• Process scope — product type, dosage form, facility class, target markets
• Applicable regs — FDA CGMP, ICH, WHO, PIC/S, EU GMP, local requirements
• QMS context — document numbering, approval matrix, related SOPs
• Equipment — asset IDs, calibration/maintenance/qualification status
• Record systems — paper vs electronic, Part 11 status
• Inspection history — FDA 483s, warning letters, open CAPAs
• SME/approver list — production, QA, QC, engineering, management

SOP Sections

1. Document Control Page

Field	Content
SOP Title	Precise scope (process/area)
SOP ID	Site numbering convention
Version	Numeric or semantic
Effective Date	Approved use date
Supersedes	Prior SOP ID/version
Prepared By	Name, role, date
Reviewed By	QA, SMEs
Approved By	QA/Management
Distribution	Controlled locations
Related SOPs	IDs and titles
Electronic Signatures	Part 11 status

2. Purpose and Scope

Purpose:
This SOP establishes controlled steps for [process] to ensure GMP compliance under [reg citations].

Scope:
Applies to [areas, equipment, product types, personnel]. Excludes [exclusions with rationale].
Interfaces: [related SOP IDs].

3. Regulatory Basis

List only applicable regulations. Use [VERIFY] for unconfirmed citations.

Authority	Citation
FDA CGMP	21 CFR Parts 210/211
Electronic records	21 CFR Part 11
ICH	Q7 (API), Q9, Q10
WHO	TRS GMP guidance
PIC/S	GMP Guide
EU	EU GMP Guide + Annexes

4. Definitions

Provide GMP-aligned definitions consistent with site QMS. Minimum set: CPP, CQA, deviation, OOS, OOT, batch record, validation, qualification, calibration.

5. Responsibilities Matrix

Role	Duties	Decisions/Approvals	Records Owned
Production	Execute SOP steps	Stop work for deviations	Batch records
QA	Approve SOP, review deviations	Release/closure authority	QA review logs
QC	Testing, sampling	OOS disposition	Lab records
Engineering	Maintenance/calibration	Equipment readiness	PM/calibration logs
Management	Resource allocation	Final approval	Training matrix

6. Materials, Equipment, and Utilities

Item	ID/Spec	Qualification	Calibration/PM	Acceptance Criteria
Equipment	Asset ID	IQ/OQ/PQ status	Frequency	Tolerance
Materials	Grade/spec	Supplier status	Storage	COA required
Utilities	Water/HVAC/gases	Monitoring	Limits	Action levels

7. Procedure Steps

Each step must specify role, action, records, and acceptance criteria.

Step	Role	Action	CPP/CQA	Hold Point	Records
1	Production	[imperative action]	[range]	QA if required	[record]
2	QC	[sample/test]	[spec]	QA review	[record]
3	QA	[verification]	N/A	Release	[record]

Step rules:

• Include decision points and stop-work criteria
• Define acceptance ranges for all CPPs/CQAs
• State required PPE/cleanroom behavior where applicable
• Require documentation at time of action (concurrent recording)

8. In-Process Controls

Control	Frequency	Method	Acceptance	Action if OOR
[Control]	[per batch/time]	[method]	[spec]	[action]

9. Deviations, OOS/OOT, and CAPA

• Document deviation within same shift or defined timeframe
• Quarantine affected material/lots
• Initiate root cause investigation
• Assess impact on product quality and patient safety
• Implement CAPA with effectiveness checks
• Document QA disposition and release decision

10. Documentation and Records

Record	Owner	System	Review Timeline	Retention
Batch record	Production	Paper/eQMS	[timeframe]	Per 21 CFR 211.180 [VERIFY]
Calibration log	Engineering	Paper/eQMS	[timeframe]	[policy]
Training record	QA/HR	LMS/eQMS	[timeframe]	[policy]

If electronic: require validation, audit trails, access control, e-signatures per Part 11.

11. Training and Qualification

• Initial training before first execution
• Retraining on each revision
• Qualification for roles with critical steps
• Document training effectiveness

12. Change Control and Revision History

Version	Effective Date	Change Summary	Rationale	Approvers
1.0	[date]	Initial release	[reason]	[names]

13. References

List all cited standards with version/date. Mark uncertain items [VERIFY].

14. Appendices

Include controlled templates: SOP execution checklist, batch record template, deviation report template, in-process control log, equipment cleaning log.

Pitfalls and Checks

• Language — use imperative, unambiguous phrasing; never advisory ("should consider")
• Citations — verify all regulatory citations are current; mark uncertain ones [VERIFY]
• Role segregation — maintain separation between production and QA/QC functions
• Retention — apply the strictest applicable retention requirement across jurisdictions
• Jurisdiction — add annexes for non-U.S. markets (EU, WHO, PIC/S requirements)
• Part 11 — confirm electronic record controls whenever eQMS or e-signatures are used